Previous 10 | Next 10 |
REDWOOD CITY, CA / ACCESSWIRE / June 5, 2023 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced the successful completion of the f...
2023-05-10 20:38:09 ET Avinger, Inc. (AVGR) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Matt Kreps – Darrow Associates Investor Relations Jeff Soinski – Chief Executive Officer Nabeel Subainati – Principal Fi...
2023-05-10 16:27:02 ET Avinger press release ( NASDAQ: AVGR ): Q1 GAAP EPS of -$0.71 misses by $0.22 . Revenue of $1.89M (-0.5% Y/Y) misses by $0.11M . For further details see: Avinger GAAP EPS of -$0.71 misses by $0.22, revenue of $1.89M misses by $0.11M
REDWOOD CITY, CA / ACCESSWIRE / May 10, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the fir...
REDWOOD CITY, CA / ACCESSWIRE / May 2, 2023 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial ...
REDWOOD CITY, CA / ACCESSWIRE / April 28, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the presentation ...
2023-04-26 08:22:28 ET Avinger ( NASDAQ: AVGR ) has announced that the Co. has received 510(k) clearance from the U.S. FDA for Tigereye ® ST, its next-generation image-guided chronic total occlusion crossing system. Tigereye ST expands and advances Avinger's propr...
REDWOOD CITY, CA / ACCESSWIRE / April 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced the company has received 510(k) ...
2023-03-15 21:15:07 ET Avinger, Inc (AVGR) Q4 2022 Earnings Call March 15, 2023 4:30 PM Company Participants Matt Kreps - Darrow Associates Investor Relations Jeff Soinski - President, CEO & Director Nabeel Subainati - VP, Controller, Principal Financial Offi...
2023-03-15 16:16:58 ET Avinger press release ( NASDAQ: AVGR ): Q4 GAAP EPS of -$0.70. Revenue of $2M (-16.7% Y/Y). For further details see: Avinger GAAP EPS of -$0.70, revenue of $2M
News, Short Squeeze, Breakout and More Instantly...
$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 17, 2024 / Avinger, Inc. (NASDAQ:AVGR) , a commercial-stage medical device company developing and mar...
$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 14, 2024 / Avinger, Inc. (NASDAQ:AVGR) , a commercial-stage medical device company developing and mar...
REDWOOD CITY, CA / ACCESSWIRE / June 5, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced that it will incre...